Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mismatch Repair01:20

Mismatch Repair

Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
Mismatch Repair01:36

Mismatch Repair

Overview
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Differences between mitotically old and young endometrial tumors.

The Journal of pathology·2026
Same author

Annotation-Based Gene-Peak Links Improve Regulatory Network Prediction of Gene Expression in Human Kidney Multi-Omics.

bioRxiv : the preprint server for biology·2026
Same author

Fluctuating DNA methylation sites encode colorectal tumour growth history.

bioRxiv : the preprint server for biology·2026
Same author

Conception-calibrated male pediatric tumor mitotic clocks.

Communications biology·2026
Same author

PHYFUM: Phylogenetic Reconstruction of Normal and Pre-malignant Tissue Evolution Using Fluctuating Methylation.

bioRxiv : the preprint server for biology·2026
Same author

Aggressive Neuroblastomas Start Growing after Infancy.

bioRxiv : the preprint server for biology·2026

Related Experiment Video

Updated: Jul 18, 2026

A High-Throughput In Situ Method for Estimation of Hepatocyte Nuclear Ploidy in Mice
08:44

A High-Throughput In Situ Method for Estimation of Hepatocyte Nuclear Ploidy in Mice

Published on: April 19, 2020

When does MMR loss occur during HNPCC progression?

Darryl Shibata1

  • 1University of Southern California, Keck School of Medicine, Los Angeles, CA 90033, USA. dshibata@hsc.usc.edu

Cancer Biomarkers : Section a of Disease Markers
|December 29, 2006
PubMed
Summary

DNA mismatch repair (MMR) loss, a key event in colorectal cancer, occurs later in cancer progression than previously thought. This finding impacts our understanding of tumor development and hereditary nonpolyposis colorectal cancer (HNPCC).

Related Experiment Videos

Last Updated: Jul 18, 2026

A High-Throughput In Situ Method for Estimation of Hepatocyte Nuclear Ploidy in Mice
08:44

A High-Throughput In Situ Method for Estimation of Hepatocyte Nuclear Ploidy in Mice

Published on: April 19, 2020

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Inactivation of DNA mismatch repair (MMR) is a critical step in colorectal cancer development, particularly in hereditary nonpolyposis colorectal cancer (HNPCC) and microsatellite instability-positive (MSI+) cancers.
  • MMR deficiency leads to a significant increase in mutation rates, especially in microsatellite (MS) regions, contributing to tumor evolution.

Purpose of the Study:

  • To estimate the timing of MMR loss during the progression of MSI+ colorectal cancer using a somatic molecular clock approach.
  • To determine whether MMR loss occurs early in normal-appearing colon tissue or later in the cancer development process.

Main Methods:

  • Utilized a somatic molecular clock approach by quantifying the number of MS mutations in MSI+ colorectal cancers.
  • Correlated the number of MS mutations with the estimated interval since MMR loss.

Main Results:

  • The somatic molecular clock analysis suggests that MMR loss occurs relatively late in the progression of MSI+ colorectal cancer, rather than as an early event.
  • MMR loss appears to precede clonal expansion and transformation, but at a later stage than previously hypothesized.

Conclusions:

  • MMR loss is a late-stage event in the development of MSI+ colorectal cancer.
  • This revised understanding of MMR loss timing has implications for cancer research, diagnostics, and therapeutic strategies for HNPCC and sporadic MSI+ colorectal cancers.